trending Market Intelligence /marketintelligence/en/news-insights/trending/zfdeomz3quhbbymxctd_2a2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Achieve Life Sciences prices $12M underwritten public offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Achieve Life Sciences prices $12M underwritten public offering

Achieve Life Sciences Inc. priced a $12 million underwritten public offering.

The offering comprises class A units, priced $4 per unit, and class B units, priced $1,000 apiece.

Each class A unit consists of 1 common share and a five-year warrant to buy 1 common share. Each class B unit comprises one share of series A preferred stock — convertible into 250 shares — and a five-year warrant to buy 250 common shares. The warrants have an exercise price of $4 per share. The securities that make up the units will be issued separately.

The pharmaceutical company said it is offering a total of 710,500 common shares, 9,158 shares of series A preferred stock, convertible into 2,289,500 common shares, and total warrants to buy 3 million common shares.

The underwriters have an option to buy up to 450,000 common shares or warrants to buy up to 450,000 common shares.

The offering is expected to close on or about June 19.

Ladenburg Thalmann Financial Services Inc. unit Ladenburg Thalmann & Co. Inc. is the sole book-running manager for the offering.

Bothell, Wash.-based Achieve Life Sciences develops and sells therapies that address treatment resistance in cancer patients.